-       Report 
- October 2025
-  381 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- July 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- December 2023
-  180 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- May 2024
-  200 Pages 
- Global 
   From       €3712EUR$4,150USD£3,265GBP 
           -       Report 
- June 2023
-  74 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
               The Antidotes market is a subset of the Drugs by Therapeutic Area market, focusing on drugs used to counteract the effects of a poison or toxin. Antidotes are used to treat a wide range of conditions, from acute poisoning to chronic illnesses. They can be administered orally, intravenously, or topically, depending on the type of poison or toxin. Antidotes can be used to treat both acute and chronic conditions, and can be used in combination with other treatments.
The Antidotes market is highly    competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Other companies in the market include AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. Show Less   Read more